Emcure Pharmaceuticals Ltd. (EMCURE) Pharmaceuticals Share Price near 52-week high as stock trades at Rs 2,383.80
- November 18, 2026
- Posted by: Chaitanya Auti
- Category: News
Emcure Pharmaceuticals Share Price is Rs 2,383.80, up 1.92%, and trading near its 52-week high. The company’s market capitalisation stands at Rs 44,378.06 crore, keeping Emcure Pharmaceuticals Share Price in focus for market watchers.
Emcure Pharmaceuticals Share Price is Rs 2,383.80 at 18 November 2026 at 11:22 AM IST, up 1.92% from the previous close of Rs 2,339. The stock is trading close to its 52-week high after touching an intraday high of Rs 2,384.95, while market capitalisation stands at Rs 44,378.06 crore. That makes Emcure Pharmaceuticals Share Price one of the day’s notable stock news items in the healthcare space. According to latest Univest data, the price event is clear, but it does not establish a company-specific catalyst. For investors tracking Emcure Pharmaceuticals Share Price Today, the focus is on the exact move, the price band, and the fundamental profile behind the stock’s current valuation.
Emcure Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,383.8 |
| Previous Close | Rs 2,339 |
| Today's Move | +Rs 44.8 (+1.92%) |
| Open | Rs 2,350 |
| High | Rs 2,384.95 |
| Low | Rs 2,344 |
| Market Capitalisation | Rs 44,378.06 crore |
Emcure Pharmaceuticals Ltd. (EMCURE) traded at Rs 2,383.8 versus the previous close of Rs 2,339, a rise of 1.92%. The stock opened at Rs 2,350, reached a high of Rs 2,384.95 and touched a low of Rs 2,344.
Emcure Pharmaceuticals Share Price Today shows a gain of Rs 44.80 from the previous close, with the stock opening at Rs 2,350 and moving between Rs 2,344 and Rs 2,384.95 during the trading window captured at 18 November 2026 at 11:22 AM IST. The current quote of Rs 2,383.80 places Emcure Pharmaceuticals Share Price within a narrow distance of its yearly high, which is why the stock is appearing in 52 week high searches and broader share market today screens. For readers following Emcure Pharmaceuticals Share Price News, the most important factual point is that the stock is trading very close to its peak band for the year, while the latest Univest data confirms the price event without assigning a reason. Emcure Pharmaceuticals Share Price therefore remains a live market update rather than a finished-day outcome.
Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 44,378.06 crore |
| P/E Ratio | 40.58x |
| P/B Ratio | 8.3x |
| ROE | 20.09% |
| ROCE | 25.25% |
| EPS | Rs 57.64 |
| Book Value Per Share | Rs 281.69 |
| Dividend Yield | 0.15% |
Emcure Pharmaceuticals Ltd. (EMCURE) fundamental metrics show P/E 40.58x, P/B 8.3x, ROE 20.09%, ROCE 25.25%. These figures provide context only and are not a buy or sell signal.
Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 44,378.06 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 40.58x, P/B at 8.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.09% and ROCE of 25.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 57.64, book value per share of Rs 281.69, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.36x, median ROE of 11.22%, median ROCE of 12.76%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 40.58x |
| Benchmark Median P/E | 26.36x |
| Benchmark Average P/E | 50.53x |
| Benchmark P/E Range | 0x to 1,425.63x |
| Company P/B Ratio | 8.3x |
| Benchmark Median P/B | 2.73x |
| Company ROE | 20.09% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 25.25% |
| Benchmark Median ROCE | 12.76% |
| Company Market Capitalisation | Rs 44,378.06 crore |
| Benchmark Median Market Cap | Rs 747.19 crore |
Emcure Pharmaceuticals Ltd. (EMCURE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 40.58x, which is above the benchmark median of 26.36x, a difference of +53.95%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Emcure Pharmaceuticals Ltd. (EMCURE) has a ROE of 20.09%, which is above the benchmark median of 11.22%, a difference of +79.06%. Emcure Pharmaceuticals Ltd. (EMCURE) has a ROCE of 25.25%, which is above the benchmark median of 12.76%, a difference of +97.88%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 44,875.66 | 39.8 | 24.26 | 48.76 | 66.79 |
| Ajanta Pharma Ltd. | AJANTPHARM | 41,969.99 | 32.76 | 8.52 | 25.42 | 32.67 |
| Ipca Laboratories Ltd. | IPCALAB | 47,360.23 | 33.17 | 5.36 | 15.88 | 19.41 |
| SAI LIFE SCIENCES LIMITED | SAILIFE | 38,264.53 | 98.97 | 13.85 | 15.16 | 20.97 |
| Anthem Biosciences Ltd. | ANTHEM | 52,516.57 | 84.82 | 15.87 | 21.98 | 29.62 |
Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 40.58x compared with the displayed peer median of 39.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.09% compares with a peer median of 21.98% across the companies shown in the table. ROCE stood at 25.25% versus the displayed peer median of 29.62%, providing a capital-efficiency comparison. Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 44,378.06 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Emcure Pharmaceuticals
- Emcure Pharmaceuticals Share Price is trading at Rs 2,383.80, close to its 52-week high band.
- The day’s move in Emcure Pharmaceuticals Share Price is 1.92%, with a rise of Rs 44.80 from the previous close.
- Emcure Pharmaceuticals Share Price has a P/E ratio of 40.58 and a P/B ratio of 8.3.
- ROE at 20.09% and ROCE at 25.25% provide direct fundamental context for Emcure Pharmaceuticals Share Price.
- Emcure Pharmaceuticals Share Price stands near peers such as Glaxosmithkline Pharmaceuticals and Ajanta Pharma by market cap.
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Emcure Pharmaceuticals Share Price reflects a listed company with a market capitalisation of Rs 44,378.06 crore and a quarterly revenue figure of Rs 2,820.47 crore for Sep 2026. The company’s reported EPS is Rs 57.64, book value per share is Rs 281.69 and dividend yield is 0.15%. For readers following Emcure Pharmaceuticals Share Price Today, these are the core company details available in the latest stock news flow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Emcure Pharmaceuticals Share Price in focus today?
What is Emcure Pharmaceuticals Share Price today?
Ans. Emcure Pharmaceuticals Share Price today is Rs 2,383.80 at 18 November 2026 at 11:22 AM IST. It is higher than the previous close of Rs 2,339 and sits near the year’s peak zone.
How much did Emcure Pharmaceuticals Share Price move today?
Ans. Emcure Pharmaceuticals Share Price moved up by Rs 44.80, which equals 1.92%. The stock also traded between Rs 2,344 and Rs 2,384.95 during the session captured in the latest market update.
Is Emcure Pharmaceuticals Share Price near its 52-week high?
Ans. Yes. Emcure Pharmaceuticals Share Price is trading very close to its 52-week high after touching Rs 2,384.95 intraday. The latest price of Rs 2,383.80 keeps it in that range.
What valuation details matter for Emcure Pharmaceuticals Share Price?
Ans. Emcure Pharmaceuticals Share Price is backed by a P/E of 40.58, P/B of 8.3, EPS of Rs 57.64 and book value of Rs 281.69. Dividend yield is 0.15%, giving a full valuation view.
How does Emcure Pharmaceuticals compare with sector benchmarks?
Ans. Emcure Pharmaceuticals Share Price stands above the industry median P/E of 26.36 and median P/B of 2.73. Its ROE of 20.09% and ROCE of 25.25% are also above the benchmark medians.
How does Emcure Pharmaceuticals compare with peers?
Ans. Emcure Pharmaceuticals Share Price is close in market cap to Glaxosmithkline Pharmaceuticals and higher than Ajanta Pharma. Its P/E is above Ajanta and Ipca, while ROE and ROCE sit in the middle of the peer set.
What should investors monitor next in Emcure Pharmaceuticals Share Price?
Ans. Investors following Emcure Pharmaceuticals Share Price can monitor how the stock behaves around its current yearly high zone, along with quarterly revenue trends, earnings delivery, valuation multiples and peer comparisons over time.
Track Emcure Pharmaceuticals Share Price on Univest
Use Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Emcure Pharmaceuticals Share Price on Univest to follow live price updates, market cap, valuation ratios, sector context, 52-week levels and company financials in one place. Emcure Pharmaceuticals Share Price Today pages also help readers compare the stock with peers and review current stock news and market update data.